GlassScriptPhysician profile
Akash Nabh
NPI 1437325313
$7,002.10
in general payments reported to CMS, 2019-2025
38 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $508 · 2021: $960 · 2022: $1,707 · 2023: $1,135 · 2024: $1,200 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,276 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,275.96 |
| Education | $118.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,455.39 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $849.11 | 2019-2024 | Xifaxan, Trulance, Plenvu |
| Janssen Biotech, INC. | $674.38 | 2019-2025 | Tremfya, Simponi, Stelara |
| Celgene Corporation | $404.70 | 2021-2024 | Zeposia |
| Pfizer INC. | $401.17 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $346.97 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $258.60 | 2019-2024 | Entyvio |
| Lilly USA, LLC | $242.33 | 2023-2025 | Omvoh |
| Redhill Biopharma INC. | $236.31 | 2020-2024 | Talicia |
| Nestle Healthcare Nutrition INC. | $235.72 | 2020-2023 | |
| Genzyme Corporation | $226.51 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $174.64 | 2019-2023 | Dificid |
| Medtronic, INC. | $149.96 | 2021-2024 | Manoscan |
| Csl Behring | $136.75 | 2019-2025 | Kcentra |
| Braintree Laboratories, INC. | $112.80 | 2019-2024 | Suflave, Sutab |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $111.14 | 2024-2025 | Vowst |
| Allergan, INC. | $109.42 | 2019 | |
| Phathom Pharmaceuticals, INC. | $97.68 | 2024-2025 | Voquezna |
| Lucid Diagnostics INC. | $93.80 | 2024 | |
| Olympus America INC. | $90.93 | 2023-2025 | Disposable Biopsy Forceps, Single Use Repositionable Clip, Endoclot Sis |
| Celltrion USA INC. | $58.88 | 2023-2024 | Vegzelma, Yuflyma, Zymfentra |
| Daiichi Sankyo INC. | $57.67 | 2020 | |
| Madrigal Pharmaceuticals | $54.76 | 2025 | Rezdiffra |
| Ironwood Pharmaceuticals, INC | $50.21 | 2020-2023 | Linzess |
| Ardelyx, INC. | $45.30 | 2023-2024 | Ibsrela |
| Ferring Pharmaceuticals INC. | $43.98 | 2019-2024 | Rebyota |
| Alfasigma USA, INC. | $40.04 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $35.33 | 2022-2025 | |
| Fresenius Kabi USA, LLC | $32.40 | 2023 | Idacio |
| Ethicon US, LLC | $31.32 | 2021 | |
| Digestive Care, INC. | $25.55 | 2023 | Pertzye |
| Exact Sciences Corporation | $23.62 | 2024 | Cologuard Collection Kit |
| Axonics, INC. | $20.44 | 2022 | |
| Pharmacosmos Therapeutics INC. | $19.77 | 2022 | |
| Intra-Sana Laboratories | $16.13 | 2021 | |
| Evoke Pharma, INC. | $14.16 | 2024 | |
| Amgen INC. | $12.41 | 2022 | |
| W. L. Gore & Associates, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Nabh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.